4. maj 1994 je bil sreda pod znakom zvezdice ♉. Bil je 123 dan v letu. Predsednik Združenih držav je bil William J. (Bill) Clinton.
Če ste rojeni na ta dan, ste stari 32 let. Vaš zadnji rojstni dan je bil ponedeljek, 4. maj 2026, pred 47 dnevi. Vaš naslednji rojstni dan je torek, 4. maj 2027, čez 317 dni. Živeli ste 11.735 dni ali približno 281.647 ur, ali približno 16.898.827 minut ali približno 1.013.929.620 sekund.
Date: 04 May 1994
By Bloomberg News
Bloomberg News
The News Corporation Ltd. said today that Andrew Knight would step down as chairman of Times Newspapers Ltd. and News International P.L.C. on July 1. Mr. Knight, who is 54, will remain as a nonexecutive director of Times Newspapers and News International and will remain a director of the News Corporation.
Date: 04 May 1994
By Gwen Ifill
Gwen Ifill
Saying that the United States "cannot turn our back on the world," President Clinton offered a broad defense tonight of his foreign policy initiatives and issued tough-sounding challenges to North Korea and other foreign governments. "America cannot solve every problem, and must not become the world's policeman," he said in an international forum televised by Cable News Network. "But we have an obligation to join with others to do what we can to relieve the suffering and restore peace."
Date: 04 May 1994
By Louis Uchitelle
Louis Uchitelle
With their sales rising smartly, a majority of America's top executives are far more sanguine about the economy than the general public is, the latest New York Times/CBS News Poll shows. But many executives also have a complaint: they can't get the price increases that many say are needed to keep their businesses thriving. The executives favor, in effect, a bit more inflation -- for their industries, at least -- than the current mild national level.
Date: 04 May 1994
Last night's appearance by President Clinton was billed as a "Global Forum," but only a few parts of the world could have had any immediate knowledge of it. While CNN is available in 62 million homes in the United States and more than 50 million in Western Europe, the figure for the rest of the world is under 30 million. While the program was seen in prime time in the United States, it would have been seen after midnight or later in Europe and Africa. It was dawn in much of Asia.
Date: 05 May 1994
By Bloomberg News
Bloomberg News
The Newell Company signed a letter of intent yesterday to buy the Faber-Castell Corporation of Parsippany, N.J., a maker of writing instruments maker, by June. Terms of the deal were not disclosed. Newell, of Freeport, Ill., makes housewares, hardware and home furnishings, office and other consumer products. Its stock slipped 37.5 cents, to $39.75, yesterday on the New York Stock Exchange. Faber-Castell, which was founded in 1843 and is privately held, makes a full line of writing instruments, including wood-cased pencils and rolling ball pens.
Date: 04 May 1994
By Bloomberg News
Bloomberg News
The Danaher Corporation said yesterday that it had signed a letter of intent to acquire Moog Controls Inc., a maker of motion control systems, for an undisclosed amount. Danaher, based in Washington, said the acquisition was expected to be completed in the next several months. Moog Controls, formerly a unit of Moog Inc., has annual revenue of $25 million, Danaher said. Last month, Danaher failed in an attempt to acquire the Mark Controls Corporation.
Date: 05 May 1994
By Bloomberg News
Bloomberg News
The Office of the Comptroller of the Currency yesterday approved Mellon Bank's application to acquire the Dreyfus Corporation, the nation's sixth-largest mutual fund company. Mellon Bank and Dreyfus agreed to merge in a deal valued at $1.85 billion last December. The proposal set off a debate about the regulation of mutual fund sales by banks. Dreyfus manages about 130 mutual funds with about $80 billion in assets. The merger will create a diversified financial services company with more than $3 billion in revenue and about $215 billion under management. The comptroller's approval subjects the bank and its operating subsidiaries to several conditions, which the agency said it planned to enforce "through appropriate supervisory and legal actions."
Date: 05 May 1994
By Bloomberg News
Bloomberg News
The Jefferson Smurfit Corporation completed a $250 million initial public offering yesterday that raised 16 percent less than its target when it first announced plans to sell stock as part of a $2.45 billion recapitalization. The debt-laden paperboard company sold more than 19.2 million shares at $13 each. The St. Louis-based company had hoped to raise about $300 million by selling more than 17.2 million shares, about a 16 percent stake, for a price of $16 to $19. The shares closed at $13.25 in Nasdaq trading of almost 2.9 million shares. The company, with 1993 sales of $2.95 billion, is one of the country's largest producers of paperboard and packaging materials.
Date: 05 May 1994
By Bloomberg News
Bloomberg News
The stock of Littlefield, Adams & Company resumed trading yesterday after being halted for more than a month and closed at 41.8 percent below the value it was halted at. Shares of the San Antonio T-shirt and medical-supply company closed at $8, down $5.75. Littlefield, Adams shares had not traded since March 31, when the American Stock Exchange had halted trading in the stock so the company could file its year-end financial statements for 1993. The filing was delayed repeatedly, partly because the exchange asked Littlefield to restate its previous three quarterly statements. The restated financials were released yesterday. The Securities and Exchange Commission is investigating the company's accounting practices and several recent acquisitions, Littlefield has said.
Date: 04 May 1994
By Bloomberg News
Bloomberg News
Bayer A.G., the German chemicals and pharmaceuticals conglomerate, will pay $13.5 million for a stake of about 15 percent in Onyx Pharmaceuticals, a biotechnology company in Richmond, Calif. Bayer said it was acquiring the stake to make inroads into cancer research in the United States. Miles Inc., Bayer's United States subsidiary, will finance a joint research and development program over five years. Bayer said Miles would pay $25 million for research by Onyx and would cover all preclinical trial costs. In return, Miles would have exclusive development and marketing rights for products that emerged from that cooperation.